Amgen (AMGN) Earnings Date, Estimates & Call Transcripts → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free AMGN Stock Alerts $304.72 -0.30 (-0.10%) (As of 04:14 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 2) $3.96 Beat By $0.20 Consensus EPS (May. 2) $3.76 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. Amgen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$3.64$4.86$4.10 Q2 20244$4.78$5.14$4.96 Q3 20244$4.95$5.33$5.15 Q4 20244$4.81$5.59$5.24 FY 202416$18.18$20.92$19.45 Q1 20252$4.69$4.81$4.75 Q2 20252$5.07$5.19$5.13 Q3 20252$5.24$5.35$5.30 Q4 20252$3.91$5.48$4.70 FY 20258$18.91$20.83$19.87 Q1 20261$4.80$4.80$4.80 AMGN Earnings Date and InformationAmgen last posted its quarterly earnings data on May 2nd, 2024. The medical research company reported $3.96 earnings per share for the quarter, beating analysts' consensus estimates of $3.76 by $0.20. The company had revenue of $7.45 billion for the quarter, compared to analysts' expectations of $7.45 billion. Its revenue was up 22.0% on a year-over-year basis. Amgen has generated $7.00 earnings per share over the last year ($7.00 diluted earnings per share) and currently has a price-to-earnings ratio of 43.2. Earnings for Amgen are expected to grow by 5.60% in the coming year, from $19.47 to $20.56 per share. Amgen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Amgen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/2/2024Q1 2024$3.76$3.96+$0.20$8.13$7.45 billion$7.45 billion 2/6/2024Q4 2023$4.66$4.71+$0.05$8.00$8.13 billion$8.20 billion 10/31/2023Q3 2023$4.65$4.96+$0.31$6.70$6.92 billion$6.90 billion 8/3/2023Q2 2023$4.44$5.00+$0.56$7.43$6.66 billion$7.00 billion 4/27/2023Q1 2023$3.84$3.98+$0.14$2.68$6.18 billion$6.11 billion 2/7/2023Q4 2022$4.04$4.09+$0.05$5.18$6.77 billion$6.84 billion Nvidia needs this one obscure firm (Ad)In my new investigation, I detail why this is the single most important factor in the future of AI. I explain what this Keystone technology is… why it’s so critical to the future of not just AI but mankind… You must read this new presentation from Porter Stansberry.11/3/2022Q3 2022$4.43$4.70+$0.27$5.42$6.56 billion$6.65 billion 8/4/2022Q2 2022$4.40$4.65+$0.25$6.85$6.53 billion$6.59 billion 4/27/2022Q1 2022$4.22$4.25+$0.03$5.82$6.09 billion$6.24 billion 2/7/2022Q4 2021$4.14$4.36+$0.22$5.36$6.87 billion$6.85 billion11/2/2021Q3 2021$4.22$4.67+$0.45$6.03$6.70 billion$6.71 billion 8/2/2021Q2 2021$4.09$4.38+$0.29$7.95$6.43 billion$6.53 billion 4/26/2021Q1 2021$4.05$3.70($0.35)$4.57$6.30 billion$5.90 billion 2/1/2021Q4 2020$3.39$3.81+$0.42$4.86$6.57 billion$6.63 billion 11/2/2020Q3 2020$3.75$4.37+$0.62$5.31$6.38 billion$6.42 billion 7/28/2020Q2 2020$3.81$4.25+$0.44$5.45$6.19 billion$6.21 billion 4/30/2020Q1 2020$3.70$4.17+$0.47$5.27$6.01 billion$6.16 billion 1/30/2020Q4 2019$3.47$3.64+$0.17$4.43$6.04 billion$6.20 billion 10/29/2019Q3 2019$3.53$3.66+$0.13$4.05$5.63 billion$5.74 billion 7/30/2019Q2$3.58$3.97+$0.39$4.37$5.67 billion$5.87 billion Amgen Earnings - Frequently Asked Questions When is Amgen's earnings date? Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on AMGN's earnings history. Did Amgen beat their earnings estimates last quarter? In the previous quarter, Amgen (NASDAQ:AMGN) reported $3.96 earnings per share (EPS) to beat the analysts' consensus estimate of $3.76 by $0.20. Learn more on analysts' earnings estimate vs. AMGN's actual earnings. How can I listen to Amgen's earnings conference call? The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call How can I read Amgen's conference call transcript? The conference call transcript for Amgen's latest earnings report can be read online. Read Transcript How much revenue does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded annual revenue of $28.19 billion. How much profit does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded net income of $6.72 billion. AMGN has generated $7.00 earnings per share over the last four quarters. What is Amgen's price-to-earnings ratio? Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 43.20 and a forward price-to-earnings ratio of 15.53. The price/earnings-to-growth ratio is 2.76. What is Amgen's EPS forecast for next year? Amgen's earnings are expected to grow from $19.47 per share to $20.56 per share in the next year, which is a 5.60% increase. More Earnings Resources from MarketBeat Related Companies: Vertex Pharmaceuticals Earnings Results Regeneron Pharmaceuticals Earnings Results Gilead Sciences Earnings Results Moderna Earnings Results Seagen Earnings Results Biogen Earnings Results Alnylam Pharmaceuticals Earnings Results BioMarin Pharmaceutical Earnings Results Neurocrine Biosciences Earnings Results Incyte Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:AMGN) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Amgen Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.